Ageing and Dementia: Journal of Neural Transmission. Supplementa, cartea 53
Editat de Kurt Jellinger, Franz Fazekas, Manfred Windischen Limba Engleză Hardback – 15 iul 1998
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1378.56 lei 6-8 săpt. | |
SPRINGER VIENNA – 13 iul 1998 | 1378.56 lei 6-8 săpt. | |
Hardback (1) | 481.82 lei 3-5 săpt. | +65.50 lei 5-11 zile |
SPRINGER VIENNA – 15 iul 1998 | 481.82 lei 3-5 săpt. | +65.50 lei 5-11 zile |
Din seria Journal of Neural Transmission. Supplementa
- 5% Preț: 1052.61 lei
- 5% Preț: 407.20 lei
- Preț: 375.23 lei
- 5% Preț: 347.31 lei
- 5% Preț: 685.67 lei
- 5% Preț: 351.89 lei
- Preț: 365.43 lei
- 5% Preț: 362.28 lei
- Preț: 366.17 lei
- 15% Preț: 640.55 lei
- 5% Preț: 990.01 lei
- 5% Preț: 354.88 lei
- 5% Preț: 359.80 lei
- Preț: 376.53 lei
- 15% Preț: 619.01 lei
- Preț: 367.27 lei
- 5% Preț: 379.50 lei
- 5% Preț: 360.69 lei
- Preț: 383.02 lei
- 5% Preț: 365.07 lei
- 5% Preț: 350.65 lei
- 5% Preț: 358.94 lei
- 5% Preț: 358.21 lei
- 5% Preț: 372.48 lei
- 5% Preț: 367.71 lei
- 5% Preț: 353.67 lei
- 5% Preț: 698.36 lei
- 18% Preț: 1347.23 lei
- 5% Preț: 1314.97 lei
- 5% Preț: 1374.51 lei
- 5% Preț: 1054.21 lei
- 5% Preț: 687.46 lei
- 5% Preț: 1070.93 lei
- 5% Preț: 1015.42 lei
- 5% Preț: 692.53 lei
- 5% Preț: 1381.89 lei
- 5% Preț: 1304.04 lei
- 5% Preț: 1980.17 lei
Preț: 481.82 lei
Preț vechi: 507.18 lei
-5% Nou
Puncte Express: 723
Preț estimativ în valută:
92.21€ • 97.51$ • 76.92£
92.21€ • 97.51$ • 76.92£
Carte disponibilă
Livrare economică 09-23 decembrie
Livrare express 23-29 noiembrie pentru 75.49 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783211831151
ISBN-10: 3211831150
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 31 mm
Greutate: 1.45 kg
Ediția:1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
ISBN-10: 3211831150
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 31 mm
Greutate: 1.45 kg
Ediția:1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
Public țintă
ResearchCuprins
Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies.- Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study).- Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study.- The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates.- Cognitive correlates of cerebral white matter changes.- Concepts on the prognostic significance of white matter changes.- Difficulties in the clinical diagnosis of vascular dementia and dementia of the Alzheimer type — comparison of clinical classifications.- Problems of differential diagnosis between depressive pseudo- dementia and Alzheimer’s disease.- The neuropathological diagnosis of Alzheimer disease.- The progression of the lesions in Alzheimer disease: insights from a prospective clinico- pathological study.- Evolution of neuronal changes in the course of Alzheimer’s disease.- The cytoskeleton in Alzheimer disease.- Mechanisms of synaptic pathology in Alzheimer’s disease.- Proteolytic processing of Alzheimer’s disease associated proteins.- Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.- Presenilins and Alzheimer’s disease: the role of A?42.- Biological markers for the diagnosis of Alz- heimer’s disease.- Apolipoprotein E4, cholinergic integrity and the pharmaco- genetics of Alzheimer’s disease.- Cerebrospinal fluid levels of A?42 and tau: potential markers of Alzheimer’s disease.- Combination of the different biological markers for increasing specificity of in vivo Alzheimer’s testing.- Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia.- Current diagnostic methods andoutcome variables for clinical investigation of Alzheimer’s disease.- Perspectives in clinical Alzheimer’s disease research and the development of antidementia drugs.- The role of glutamate in dementia.- Neurotrophic activities and therapeutic experience with a brain-derived peptide preparation.- Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats.- The influence of Cerebrolysin® and E021 on spatial navigation of 24-month-old rats.- Molecular regulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors.- Antioxidant systemic effect of short-term Cerebrolysin® administration.- Can Cerebrolysin® influence chronic deterioration of spatial learning and memory?.- Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia.- Further evidence that Cerebrolysin® protects cortical neurons from neurodegeneration in vitro.- Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro.- Dose-dependent effects of Cerebrolysin® on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia.